Prof.Dr. ID: 39068

Rainer Böger

graph of relations

Publications

  1. 2010
  2. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.

    Schulze, F., Carter, A. M., Schwedhelm, E., Ajjan, R., Maas, R., von Holten, R-A., Atzler, D., Grant, P. J. & Böger, R., 2010, In: ATHEROSCLEROSIS. 208, 2, p. 518-523 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia.

    Böger, R., Diemert, A., Schwedhelm, E., Lüneburg, N., Maas, R. & Hecher, K., 2010, In: GYNECOL OBSTET INVES. 69, 1, p. 1-13 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. 2009
  5. Nitroxyl exacerbates ischemic cerebral injury and oxidative neurotoxicity

    Choe, C., Lewerenz, J., Fischer, G., Uliasz, T. F., Espey, M. G., Hummel, F. C., King, S. B., Schwedhelm, E., Böger, R. H., Gerloff, C., Hewett, S. J., Magnus, T. & Donzelli, S., 01.09.2009, In: J NEUROCHEM. 110, 6, p. 1766-73 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. ADMA and the role of the genes: Lessons from genetically modified animals and human gene polymorphisms.

    Maas, R., Böger, R. & Lüneburg, N., 2009, In: PHARMACOL RES. 60, 6, p. 475-480 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function.

    Rudolph, V., Rudolph, T. K., Kubala, L., Clauberg, N., Maas, R., Pekarova, M., Klinke, A., Lau, D., Szöcs, K., Meinertz, T., Böger, R. & Baldus, S., 2009, In: FREE RADICAL BIO MED. 47, 11, p. 1584-1590 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice.

    Benndorf, R., Krebs, C., Hirsch-Hoffmann, B., Schwedhelm, E., Cieslar, G., Schmidt-Haupt, R., Steinmetz, O., Meyer-Schwesinger, C., Thaiss, F., Haddad, M., Fehr, S., Heilmann, A., Helmchen, U., Hein, L., Ehmke, H., Stahl, R. A. K., Böger, R. & Wenzel, U., 2009, In: KIDNEY INT. 75, 10, p. 1039-1049 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study.

    Pikula, A., Böger, R., Beiser, A. S., Maas, R., DeCarli, C., Schwedhelm, E., Himali, J. J., Schulze, F., Au, R., Kelly-Hayes, M., Kase, C. S., Vasan, R. S., Wolf, P. A. & Seshadri, S., 2009, In: STROKE. 40, 9, p. 2959-2964 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring Cohort.

    Maas, R., Xanthakis, V., Polak, J. F., Schwedhelm, E., Sullivan Lisa, M., Benndorf, R., Schulze, F., Vasan, R. S., Wolf, P. A., Böger, R. & Seshadri, S., 2009, In: STROKE. 40, 8, p. 2715-2719 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria.

    Sibal, L., Agarwal, S. C., Schwedhelm, E., Lüneburg, N., Böger, R. & Home, P. D., 2009, In: CARDIOVASC DIABETOL. 8, p. 27

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk.

    Böger, R., Maas, R., Schulze, F. & Schwedhelm, E., 2009, In: PHARMACOL RES. 60, 6, p. 481-487 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Asymmetric dimethylarginine predicts outcome and time of stay in hospital in patients attending an internal medicine emergency room.

    Schulze, F., Vollert, J., Maas, R., Müller, R., Schwedhelm, E., Müller, C., Böger, R. & Möckel, M., 2009, In: CLIN CHIM ACTA. 401, 1-2, p. 20-24 1-2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort.

    Schwedhelm, E., Xanthakis, V., Maas, R., Sullivan Lisa, M., Schulze, F., Riederer, U., Benndorf, R., Böger, R. & Vasan, R. S., 2009, In: CLIN CHEM.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Asymmetric dimethylarginine: Understanding the physiology, genetics, and clinical relevance of this novel biomarker Proceedings of the 4th International Symposium on ADMA.

    Böger, R., 2009, In: PHARMACOL RES. 60, 6, p. 447 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Dimethylarginine dimethylaminohydrolase-1 transgenic mice are not protected from ischemic stroke.

    Leypoldt, F., Choe, C-U., Gelderblom, M., von Leitner, E-C., Atzler, D., Schwedhelm, E., Gerloff, C., Sydow, K., Böger, R. & Magnus, T., 2009, In: PLOS ONE. 4, 10, p. 7337 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Ethnic-specific correlations of visfatin with circulating markers of endothelial inflammation and function.

    Reimann, M., Ziemssen, T., Huisman, H. W., Schutte, R., Malan, L., Rooyen, V., Böger, R., Böger, R. H., Malan, N. T. & Schutte, A. E., 2009, In: OBESITY. 17, 12, p. 2210-2215 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Extensive characterization of the human DDAH1 transgenic mice.

    Schwedhelm, E., von Leitner, E-C., Atzler, D., Schmitz, C., Jacobi, J., Meinertz, T., Münzel, T., Baldus, S., Cooke, J. P., Böger, R., Maas, R. & Sydow, K., 2009, In: PHARMACOL RES. 60, 6, p. 494-502 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study.

    Ostad, M. A., Eggeling, S., Tschentscher, P., Schwedhelm, E., Böger, R., Wenzel, P., Meinertz, T., Munzel, T. & Warnholtz, A., 2009, In: ATHEROSCLEROSIS. 205, 1, p. 227-232 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. HNO exacerbates ischemic cerebral injury and oxidative neurotoxicity.

    Choe, C-U., Lewerenz, J., Fischer, G., Uliasz, T. F., Espey, M. G., Hummel, F., Bruce King, S., Schwedhelm, E., Böger, R., Gerloff, C., Hewett, S. J., Magnus, T. & Donzelli, S., 2009, In: J NEUROCHEM.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Interaction of thiazolidinediones (glitazones) with the ATP-binding cassette transporters P-glycoprotein and breast cancer resistance protein.

    Weiss, J., Sauer, A., Herzog, M., Böger, R., Haefeli, W. E. & Benndorf, R., 2009, In: PHARMACOLOGY. 84, 5, p. 264-270 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides.

    Schulze, F., Glos, S., Petruschka, D., Altenburg, C., Maas, R., Benndorf, R., Schwedhelm, E., Beil, U. & Böger, R., 2009, In: NUTR RES. 29, 5, p. 291-297 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.

    Böger, R., Sullivan Lisa, M., Schwedhelm, E., Wang, T. J., Maas, R., Benjamin, E. J., Schulze, F., Xanthakis, V., Benndorf, R. & Vasan, R. S., 2009, In: CIRCULATION. 119, 12, p. 1592-1600 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample.

    Lieb, W., Benndorf, R., Benjamin, E. J., Sullivan Lisa, M., Maas, R., Xanthakis, V., Schwedhelm, E., Aragam, J., Schulze, F., Böger, R. & Vasan, R. S., 2009, In: ATHEROSCLEROSIS. 204, 1, p. 282-287 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension.

    Maas, R., Erdmann, J., Lüneburg, N., Stritzke, J., Schwedhelm, E., Meisinger, C., Peters, A., Weil, J., Schunkert, H., Böger, R. & Lieb, W., 2009, In: PHARMACOL RES. 60, 6, p. 488-493 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Renal resistance index in renal allograft recipients: a role for ADMA.

    Bergmann, I. P., Böger, R., Marti, E., Frey, F. J., Schwedhelm, E. & Eisenberger, U., 2009, In: AM J KIDNEY DIS.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis.

    Broedbaek, K., Poulsen, H. E., Weimann, A., Kom, G. D., Schwedhelm, E., Nielsen, P. & Böger, R., 2009, In: FREE RADICAL BIO MED. 47, 8, p. 1230-1233 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine.

    Hu, X., Xu, X., Zhu, G., Atzler, D., Kimoto, M., Chen, J., Schwedhelm, E., Lüneburg, N., Böger, R., Zhang, P. & Chen, Y., 2009, In: CIRCULATION. 120, 22, p. 2222-2229 22.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. 2008
  30. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.

    Galle, J., Schwedhelm, E., Pinnetti, S., Böger, R. & Wanner, C., 2008, In: NEPHROL DIAL TRANSPL. 23, 10, p. 3174-3183 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease.

    Arlt, S., Schulze, F., Eichenlaub, M., Maas, R., Lehmbeck, J., Schwedhelm, E., Jahn, H. & Böger, R., 2008, In: DEMENT GERIATR COGN. 26, 1, p. 58-64 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Effects of moderate hyperhomocysteinaemia induced by 4 weeks methionine-enriched diet on metabolite profile and mesenteric artery function in rats.

    Pexa, A., Böger, R., Henle, T., Schwedhelm, E. & Deussen, A., 2008, In: BRIT J NUTR. 99, 5, p. 993-999 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Introducing the first polymer-free leflunomide eluting stent.

    Deuse, T., Erben, R. G., Ikeno, F., Behnisch, B., Böger, R., Connolly, A. J., Reichenspurner, H., Bergow, C., Pelletier, M. P., Robbins, R. C. & Schrepfer, S., 2008, In: ATHEROSCLEROSIS. 200, 1, p. 126-134 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?

    Böger, R., 2008, In: CURR OPIN CLIN NUTR. 11, 1, p. 55-61 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

    Pergolizzi, J., Böger, R., Budd, K., Dahan, A., Erdine, S., Hans, G., Kress, H-G., Langford, R., Likar, R., Raffa, R. B. & Sacerdote, P., 2008, In: PAIN PRACT. 8, 4, p. 287-313 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease.

    Bierend, A., Rau, T., Maas, R., Schwedhelm, E. & Böger, R., 2008, In: BRIT J CLIN PHARMACO. 65, 4, p. 540-547 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.

    Schwedhelm, E., Maas, R., Freese, R., Jung, D., Lukacs, Z., Jambrecina, A., Spickler, W., Schulze, F. & Böger, R., 2008, In: BRIT J CLIN PHARMACO. 65, 1, p. 51-59 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Pleiotropic effects of telmisartan: still more to come?

    Benndorf, R. & Böger, R., 2008, In: J HYPERTENS. 26, 5, p. 854-856 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice.

    Jacobi, J., Maas, R., Cordasic, N., Koch, K., Schmieder, R. E., Böger, R. & Hilgers, K. F., 2008, In: AM J PHYSIOL-HEART C. 294, 2, p. 1058-1066 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia.

    Maas, R., Schwedhelm, E., Kahl, L., Li, H., Benndorf, R., Lüneburg, N., Förstermann, U. & Böger, R., 2008, In: CLIN CHEM. 54, 2, p. 292-300 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. 2007
  42. Acute effects of various fast-food meals on vascular function and cardiovascular disease risk markers: the Hamburg Burger Trial.

    Rudolph, T. K., Ruempler, K., Schwedhelm, E., Tan-Andresen, J., Riederer, U., Böger, R. & Maas, R., 2007, In: AM J CLIN NUTR. 86, 2, p. 334-340 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Arterial wave reflections and determinants of endothelial function a hypothesis based on peripheral mode of action.

    Weber, T., Maas, R., Auer, J., Lamm, G., Lassnig, E., Rammer, M., O'Rourke, M. F., Böger, R. & Eber, B., 2007, In: AM J HYPERTENS. 20, 3, p. 256-262 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. A stable-isotope based technique for the determination of dimethylarginine dimethylaminohydrolase (DDAH) activity in mouse tissue.

    Maas, R., Tan-Andreesen, J., Schwedhelm, E., Schulze, F. & Böger, R., 2007, In: J CHROMATOGR B. 851, 1-2, p. 220-228 1-2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia.

    Maas, R., Quitzau, K., Schwedhelm, E., Spieker, L., Rafflenbeul, W., Steenpass, A., Lüscher, T. F. & Böger, R., 2007, In: ATHEROSCLEROSIS. 191, 1, p. 211-219 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections.

    Zoccali, C., Maas, R., Cutrupi, S., Pizzini, P., Finocchiaro, P., Cambareri, F., Panuccio, V., Martorano, C., Schulze, F., Enia, G., Tripepi, G. & Böger, R., 2007, In: NEPHROL DIAL TRANSPL. 22, 3, p. 801-806 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.

    Böger, G. I., Rudolph, T. K., Maas, R., Schwedhelm, E., Dumbadze, E., Bierend, A., Benndorf, R. & Böger, R., 2007, In: J AM COLL CARDIOL. 49, 23, p. 2274-2282 23.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Asymmetric dimethylarginine is associated with parameters of glucose metabolism in Caucasian but not in African women from South Africa.

    Reimann, M., Schutte, A. E., Malan, N. T., Schwarz, P. E. H., Benndorf, R., Schulze, F. & Böger, R., 2007, In: EXP CLIN ENDOCR DIAB. 115, 9, p. 600-605 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. AT1-receptor blockade with irbesartan improves peripheral but not coronary endothelial dysfunction in patients with stable coronary artery disease.

    Warnholtz, A., Ostad, M. A., Heitzer, T., Thuneke, F., Fröhlich, M., Tschentscher, P., Schwedhelm, E., Böger, R., Meinertz, T. & Munzel, T., 2007, In: ATHEROSCLEROSIS. 194, 2, p. 439-445 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.

    Maas, R., Dentz, L., Schwedhelm, E., Thoms, W., Kuß, O., Hiltmeyer, N., Haddad, M., Klöss, T., Standl, T. & Böger, R., 2007, In: CRIT CARE MED. 35, 8, p. 1876-1881 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma.

    Schwedhelm, E., Maas, R., Tan-Andresen, J., Schulze, F., Riederer, U. & Böger, R., 2007, In: J CHROMATOGR B. 851, 1-2, p. 211-219 1-2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.

    Kom, G. D., Schwedhelm, E., Maas, R., Schneider, L., Benndorf, R. & Böger, R., 2007, In: BRIT J CLIN PHARMACO. 63, 6, p. 672-679 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?

    Schrepfer, S., Deuse, T., Sultan, K., Haddad, M., Böger, R., Münzel, T., Schäfer, H., Pelletier, M. P., Robbins, R. C. & Reichenspurner, H., 2007, In: CARDIOLOGY. 108, 2, p. 128-137 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review